HomeSNDX • NASDAQ
add
Syndax Pharmaceuticals Inc
Previous close
$20.11
Day range
$20.04 - $21.11
Year range
$11.22 - $25.34
Market cap
1.72B USD
Avg Volume
928.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 79.51M | 72.80% |
Net income | -72.40M | -76.04% |
Net profit margin | — | — |
Earnings per share | -0.85 | -44.07% |
EBITDA | -79.51M | -72.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 443.16M | 1.13% |
Total assets | 543.03M | 18.09% |
Total liabilities | 51.14M | 110.27% |
Total equity | 491.89M | — |
Shares outstanding | 84.99M | — |
Price to book | 3.47 | — |
Return on assets | -34.39% | — |
Return on capital | -37.90% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -72.40M | -76.04% |
Cash from operations | -83.55M | -112.98% |
Cash from investing | -99.40M | -599.12% |
Cash from financing | 2.17M | -12.37% |
Net change in cash | -180.78M | -973.57% |
Free cash flow | -55.57M | -115.19% |
About
Founded
2005
Headquarters
Website
Employees
112